New? Free Sign Up
Then check our Welcome Center to a Community Caring about Sleep Apnea diagnosis and Sleep Apnea treatment:
CPAP machines, Sleep Apnea surgery and dental appliances.
Tags:
Mike, thanks for the clarification on why not to use antibacterials and lotions. I use ivory hand soap myself, works fine, leaves a really clean mask.
Mary Z.
Mike Myers said:Regarding the anti-bacterial soap for cleaning your equipment, our Resmed sales rep and others have always told us that the reason one is not to use anti-
When one of our contacts called us about a product
he referred to as “truly bizarre,” I thought “How ‘out there’ can it really be?” After all, we come across some pretty unique and complex stuff almost daily in the
course of our research. But in this case, there really is
no other word to describe the novel treatment for cystic
fibrosis, chronic obstructive pulmonary disease, and
other respiratory ailments that he told me about:
Bizarre sums it up nicely.
It’s a liquid formula of DNA called Mucolyxir that,
applied sublingually, helps dissolve airway-blocking
mucous. That’s right – DNA under your tongue to help
you breathe better: See what we mean by bizarre?
But not only does it appear to be safe and effective,
it also costs much less than you might expect for
something this revolutionary.
Ancient theory meets modern science
One of the primary theories explaining respiratory
diseases is that much of the mucous blocking the airways
is a result of the immune system’s effort to eliminate
bacteria from the lungs.
Mucolyxir’s developers, John McMichael and Allan
Lieberman, took that theory and further hypothesised
that such activity, over time, could result in
hypersensitivity that would exacerbate the problem of
mucous accumulation. To address this problem, they
turned to the ancient homeopathic concept of “like
cures like.”
As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula.
DNA therapy interrupts vicious cycle
Inside the lungs, the scenario might go something
like this: Bacterial-DNA induces the production of
various interleukins (such as IL-8), which are associated
with inflammation. The presence of IL-8 sends
out a distress signal through your body. In turn,
responding immune cells attack and destroy the
invaders by engulfing them in mucous. But as the
immune cells respond, they spill their own DNA,
which is interpreted as an enemy invader in the respiratory
environment. This sparks another signal for
help, establishing a vicious and continually amplified
cycle as the immune cells are repeatedly called into
play.
Mucolyxir interrupts this cycle by reducing the
production of “signalling” interleukins in order to
decrease the production of the protective mucous,
which is often more harmful than helpful. It does
this in two ways: by regulating anti-DNA activity of
the immune system, and by clearing mucous to eliminate
matter clogging the airways.
Mucociliary clearance involves the movement of
the cilia (the tiny arm-like fibres on the cells lining
the bronchial tree), secretion of mucous, and movement
of water into and out of epithelial cells. In
plain English, that means that the tiny fibres in your
lungs are stimulated, causing mucous secretion and
movement of water, which, basically, forces you to
“cough up” the material clogging your airway. The
DNA in Mucolyxir stimulates this process.
The DNA that McMichael and Lieberman used in
creating Mucolyxir was extracted from salmon, but
it’s important to understand that there is no gene
transfer with this method of DNA use. In other
words, you won’t suddenly start showing characteristics
of salmon. I spoke to Dr. Lieberman to ask how
we can be sure that there’s no risk of this happening:
After all, you don’t need gills or fins.
He explained that Mucolyxir uses a microdose of
DNA, meaning that there is not even one full
genome present in the product. He pointed out that
we eat foreign DNA all the time: When you eat a
sardine, you are eating the complete sardine DNA,
yet you don’t take on any characteristics of a sardine.
Fortunately, it just doesn’t work that way.
Dr.McMichael noted that, based on his observations,
Mucolyxir appears to be “helpful in the treatment of
severe respiratory conditions like chronic bronchitis
and COPD. People treated with it demonstrate
significant improvements in objective parameters
such as improved pulmonary function leading to better
blood oxygenation efficiency and exercise ability.
This product has been formulated to address an
unmet medical need that affects a large number of
people worldwide.”
And that “large number” is growing every day.
While cigarette smoke and work environments (such
as textile manufacturing and mining) are the most
common causes of COPD, it’s not just the smokers,
miners, and manufacturers at risk. A new generation
there is a range of antibiotics in the food consumed from milk to bacon and to use antibiotics indiscriminatly reduces their effectiveness
you should occasonally disinfect your cpap let your immune system do it job to protect you without overly disinfecting your cpap
when you are ill then is the time to disinfect and say disinfect monthly
oh a good time to disinfect is when you take your machine to the doctors or go on holidays
Mucolyxir’s developers, John McMichael and Allan
Lieberman...they turned to the ancient homeopathic
concept of “like cures like.”
Uhuh. Sure, you may believe this tripe, but the fact is, there is nothing "ancient" about Homeopathy. Developed in the late 18th century by German physician, Samuel Hahnemann, he was looking for something better than the current, dangerous practice, of blood-letting. Sadly, he chose to believe that "sympathic magic" was real ("like affects like"). A for effort, F for results.
http://www.skepdic.com/sympathetic.html
"Sympathetic magic is based on the metaphysical belief that like affects like. Sympathetic magic is the basis for most forms of divination."
"As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula."
The scammers who came up with this "cure" (COPD has no cure) believe in magic. Are we supposed to be so damned stupid, that we'll throw our money and health away?
Shame on "99" for pushing magic on people who truly need help.
99 said:When one of our contacts called us about a product
he referred to as “truly bizarre,” I thought “How ‘out there’ can it really be?” After all, we come across some pretty unique and complex stuff almost daily in the
course of our research. But in this case, there really is
no other word to describe the novel treatment for cystic
fibrosis, chronic obstructive pulmonary disease, and
other respiratory ailments that he told me about:
Bizarre sums it up nicely.
It’s a liquid formula of DNA called Mucolyxir that,
applied sublingually, helps dissolve airway-blocking
mucous. That’s right – DNA under your tongue to help
you breathe better: See what we mean by bizarre?
But not only does it appear to be safe and effective,
it also costs much less than you might expect for
something this revolutionary.
Ancient theory meets modern science
One of the primary theories explaining respiratory
diseases is that much of the mucous blocking the airways
is a result of the immune system’s effort to eliminate
bacteria from the lungs.
Mucolyxir’s developers, John McMichael and Allan
Lieberman, took that theory and further hypothesised
that such activity, over time, could result in
hypersensitivity that would exacerbate the problem of
mucous accumulation. To address this problem, they
turned to the ancient homeopathic concept of “like
cures like.”
As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula.
DNA therapy interrupts vicious cycle
Inside the lungs, the scenario might go something
like this: Bacterial-DNA induces the production of
various interleukins (such as IL-8), which are associated
with inflammation. The presence of IL-8 sends
out a distress signal through your body. In turn,
responding immune cells attack and destroy the
invaders by engulfing them in mucous. But as the
immune cells respond, they spill their own DNA,
which is interpreted as an enemy invader in the respiratory
environment. This sparks another signal for
help, establishing a vicious and continually amplified
cycle as the immune cells are repeatedly called into
play.
Mucolyxir interrupts this cycle by reducing the
production of “signalling” interleukins in order to
decrease the production of the protective mucous,
which is often more harmful than helpful. It does
this in two ways: by regulating anti-DNA activity of
the immune system, and by clearing mucous to eliminate
matter clogging the airways.
Mucociliary clearance involves the movement of
the cilia (the tiny arm-like fibres on the cells lining
the bronchial tree), secretion of mucous, and movement
of water into and out of epithelial cells. In
plain English, that means that the tiny fibres in your
lungs are stimulated, causing mucous secretion and
movement of water, which, basically, forces you to
“cough up” the material clogging your airway. The
DNA in Mucolyxir stimulates this process.
The DNA that McMichael and Lieberman used in
creating Mucolyxir was extracted from salmon, but
it’s important to understand that there is no gene
transfer with this method of DNA use. In other
words, you won’t suddenly start showing characteristics
of salmon. I spoke to Dr. Lieberman to ask how
we can be sure that there’s no risk of this happening:
After all, you don’t need gills or fins.
He explained that Mucolyxir uses a microdose of
DNA, meaning that there is not even one full
genome present in the product. He pointed out that
we eat foreign DNA all the time: When you eat a
sardine, you are eating the complete sardine DNA,
yet you don’t take on any characteristics of a sardine.
Fortunately, it just doesn’t work that way.
Dr.McMichael noted that, based on his observations,
Mucolyxir appears to be “helpful in the treatment of
severe respiratory conditions like chronic bronchitis
and COPD. People treated with it demonstrate
significant improvements in objective parameters
such as improved pulmonary function leading to better
blood oxygenation efficiency and exercise ability.
This product has been formulated to address an
unmet medical need that affects a large number of
people worldwide.”
And that “large number” is growing every day.
While cigarette smoke and work environments (such
as textile manufacturing and mining) are the most
common causes of COPD, it’s not just the smokers,
miners, and manufacturers at risk. A new generation
i truely do not remember responding in the manner described
however the fact appear to be there so as i cannot deny it
please accept my appoligy as i am in agreement with kevin supplied answer
i do not promote or push ideas that leave a lot to be desired of and ususally stick with what i do know, which is not a lot
i was surprised and taken aback to read this
Kevin Barthelemy said:Mucolyxir’s developers, John McMichael and Allan
Lieberman...they turned to the ancient homeopathic
concept of “like cures like.”
Uhuh. Sure, you may believe this tripe, but the fact is, there is nothing "ancient" about Homeopathy. Developed in the late 18th century by German physician, Samuel Hahnemann, he was looking for something better than the current, dangerous practice, of blood-letting. Sadly, he chose to believe that "sympathic magic" was real ("like affects like"). A for effort, F for results.
http://www.skepdic.com/sympathetic.html
"Sympathetic magic is based on the metaphysical belief that like affects like. Sympathetic magic is the basis for most forms of divination."
"As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula."
The scammers who came up with this "cure" (COPD has no cure) believe in magic. Are we supposed to be so damned stupid, that we'll throw our money and health away?
Shame on "99" for pushing magic on people who truly need help.
99 said:When one of our contacts called us about a product
he referred to as “truly bizarre,” I thought “How ‘out there’ can it really be?” After all, we come across some pretty unique and complex stuff almost daily in the
course of our research. But in this case, there really is
no other word to describe the novel treatment for cystic
fibrosis, chronic obstructive pulmonary disease, and
other respiratory ailments that he told me about:
Bizarre sums it up nicely.
It’s a liquid formula of DNA called Mucolyxir that,
applied sublingually, helps dissolve airway-blocking
mucous. That’s right – DNA under your tongue to help
you breathe better: See what we mean by bizarre?
But not only does it appear to be safe and effective,
it also costs much less than you might expect for
something this revolutionary.
Ancient theory meets modern science
One of the primary theories explaining respiratory
diseases is that much of the mucous blocking the airways
is a result of the immune system’s effort to eliminate
bacteria from the lungs.
Mucolyxir’s developers, John McMichael and Allan
Lieberman, took that theory and further hypothesised
that such activity, over time, could result in
hypersensitivity that would exacerbate the problem of
mucous accumulation. To address this problem, they
turned to the ancient homeopathic concept of “like
cures like.”
As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula.
DNA therapy interrupts vicious cycle
Inside the lungs, the scenario might go something
like this: Bacterial-DNA induces the production of
various interleukins (such as IL-8), which are associated
with inflammation. The presence of IL-8 sends
out a distress signal through your body. In turn,
responding immune cells attack and destroy the
invaders by engulfing them in mucous. But as the
immune cells respond, they spill their own DNA,
which is interpreted as an enemy invader in the respiratory
environment. This sparks another signal for
help, establishing a vicious and continually amplified
cycle as the immune cells are repeatedly called into
play.
Mucolyxir interrupts this cycle by reducing the
production of “signalling” interleukins in order to
decrease the production of the protective mucous,
which is often more harmful than helpful. It does
this in two ways: by regulating anti-DNA activity of
the immune system, and by clearing mucous to eliminate
matter clogging the airways.
Mucociliary clearance involves the movement of
the cilia (the tiny arm-like fibres on the cells lining
the bronchial tree), secretion of mucous, and movement
of water into and out of epithelial cells. In
plain English, that means that the tiny fibres in your
lungs are stimulated, causing mucous secretion and
movement of water, which, basically, forces you to
“cough up” the material clogging your airway. The
DNA in Mucolyxir stimulates this process.
The DNA that McMichael and Lieberman used in
creating Mucolyxir was extracted from salmon, but
it’s important to understand that there is no gene
transfer with this method of DNA use. In other
words, you won’t suddenly start showing characteristics
of salmon. I spoke to Dr. Lieberman to ask how
we can be sure that there’s no risk of this happening:
After all, you don’t need gills or fins.
He explained that Mucolyxir uses a microdose of
DNA, meaning that there is not even one full
genome present in the product. He pointed out that
we eat foreign DNA all the time: When you eat a
sardine, you are eating the complete sardine DNA,
yet you don’t take on any characteristics of a sardine.
Fortunately, it just doesn’t work that way.
Dr.McMichael noted that, based on his observations,
Mucolyxir appears to be “helpful in the treatment of
severe respiratory conditions like chronic bronchitis
and COPD. People treated with it demonstrate
significant improvements in objective parameters
such as improved pulmonary function leading to better
blood oxygenation efficiency and exercise ability.
This product has been formulated to address an
unmet medical need that affects a large number of
people worldwide.”
And that “large number” is growing every day.
While cigarette smoke and work environments (such
as textile manufacturing and mining) are the most
common causes of COPD, it’s not just the smokers,
miners, and manufacturers at risk. A new generation
Mucolyxir’s developers, John McMichael and Allan
Lieberman...they turned to the ancient homeopathic
concept of “like cures like.”
Uhuh. Sure, you may believe this tripe, but the fact is, there is nothing "ancient" about Homeopathy. Developed in the late 18th century by German physician, Samuel Hahnemann, he was looking for something better than the current, dangerous practice, of blood-letting. Sadly, he chose to believe that "sympathic magic" was real ("like affects like"). A for effort, F for results.
http://www.skepdic.com/sympathetic.html
"Sympathetic magic is based on the metaphysical belief that like affects like. Sympathetic magic is the basis for most forms of divination."
"As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula."
The scammers who came up with this "cure" (COPD has no cure) believe in magic. Are we supposed to be so damned stupid, that we'll throw our money and health away?
Shame on "99" for pushing magic on people who truly need help.
99 said:When one of our contacts called us about a product
he referred to as “truly bizarre,” I thought “How ‘out there’ can it really be?” After all, we come across some pretty unique and complex stuff almost daily in the
course of our research. But in this case, there really is
no other word to describe the novel treatment for cystic
fibrosis, chronic obstructive pulmonary disease, and
other respiratory ailments that he told me about:
Bizarre sums it up nicely.
It’s a liquid formula of DNA called Mucolyxir that,
applied sublingually, helps dissolve airway-blocking
mucous. That’s right – DNA under your tongue to help
you breathe better: See what we mean by bizarre?
But not only does it appear to be safe and effective,
it also costs much less than you might expect for
something this revolutionary.
Ancient theory meets modern science
One of the primary theories explaining respiratory
diseases is that much of the mucous blocking the airways
is a result of the immune system’s effort to eliminate
bacteria from the lungs.
Mucolyxir’s developers, John McMichael and Allan
Lieberman, took that theory and further hypothesised
that such activity, over time, could result in
hypersensitivity that would exacerbate the problem of
mucous accumulation. To address this problem, they
turned to the ancient homeopathic concept of “like
cures like.”
As you’ll see below, much of the mucous build-up
involved in respiratory illnesses like cystic fibrosis and
chronic obstructive pulmonary disease (COPD) is
caused by accumulated DNA. So McMichael and
Lieberman chose the “like” cure – DNA – as the basis
for their Mucolyxir formula.
DNA therapy interrupts vicious cycle
Inside the lungs, the scenario might go something
like this: Bacterial-DNA induces the production of
various interleukins (such as IL-8), which are associated
with inflammation. The presence of IL-8 sends
out a distress signal through your body. In turn,
responding immune cells attack and destroy the
invaders by engulfing them in mucous. But as the
immune cells respond, they spill their own DNA,
which is interpreted as an enemy invader in the respiratory
environment. This sparks another signal for
help, establishing a vicious and continually amplified
cycle as the immune cells are repeatedly called into
play.
Mucolyxir interrupts this cycle by reducing the
production of “signalling” interleukins in order to
decrease the production of the protective mucous,
which is often more harmful than helpful. It does
this in two ways: by regulating anti-DNA activity of
the immune system, and by clearing mucous to eliminate
matter clogging the airways.
Mucociliary clearance involves the movement of
the cilia (the tiny arm-like fibres on the cells lining
the bronchial tree), secretion of mucous, and movement
of water into and out of epithelial cells. In
plain English, that means that the tiny fibres in your
lungs are stimulated, causing mucous secretion and
movement of water, which, basically, forces you to
“cough up” the material clogging your airway. The
DNA in Mucolyxir stimulates this process.
The DNA that McMichael and Lieberman used in
creating Mucolyxir was extracted from salmon, but
it’s important to understand that there is no gene
transfer with this method of DNA use. In other
words, you won’t suddenly start showing characteristics
of salmon. I spoke to Dr. Lieberman to ask how
we can be sure that there’s no risk of this happening:
After all, you don’t need gills or fins.
He explained that Mucolyxir uses a microdose of
DNA, meaning that there is not even one full
genome present in the product. He pointed out that
we eat foreign DNA all the time: When you eat a
sardine, you are eating the complete sardine DNA,
yet you don’t take on any characteristics of a sardine.
Fortunately, it just doesn’t work that way.
Dr.McMichael noted that, based on his observations,
Mucolyxir appears to be “helpful in the treatment of
severe respiratory conditions like chronic bronchitis
and COPD. People treated with it demonstrate
significant improvements in objective parameters
such as improved pulmonary function leading to better
blood oxygenation efficiency and exercise ability.
This product has been formulated to address an
unmet medical need that affects a large number of
people worldwide.”
And that “large number” is growing every day.
While cigarette smoke and work environments (such
as textile manufacturing and mining) are the most
common causes of COPD, it’s not just the smokers,
miners, and manufacturers at risk. A new generation
© 2025 Created by The SleepGuide Crew.
Powered by